News about Global Pharma

Lupin Acquires Two Brands from Sanofi in Europe and Canada

Lupin has announced that its European hub entity, Lupin Atlantis Holdings SA, has completed the acquisition of two well-known brands, Aarane in Germany and Nalcrom in Canada and the Netherlands, along with the associated trademark rights, from Sanofi.

Global Pharma | 10/06/2024 | By Aishwarya |  1506

Cycle Pharmaceuticals Offers All-Cash Proposal to Acquire Vanda Pharmaceuticals

Cycle Pharmaceuticals Ltd. has confirmed that it proposed to the Board of Directors of Vanda Pharmaceuticals, Inc. to acquire 100 percent of Vanda’s issued and outstanding shares for a cash consideration of USD 8.00 per Vanda share.

Global Pharma | 07/06/2024 | By Aishwarya |  835

CordenPharma Announces Partnership with Certest

CordenPharma has signed a collaboration agreement with Certest, a Spanish company focused on the development of new products with special emphasis in Drug Delivery with LNPs and API synthesis.

Global Pharma | 07/06/2024 | By Aishwarya |  414

Aterian Investment Partners Acquires Contract Pharmaceuticals

Aterian Investment Partners has announced the acquisition of Contract Pharmaceuticals Ltd. Canada, a leading North American contract development and manufacturing organization (CDMO) of non-sterile liquid and semi-solid dosage forms.

Global Pharma | 07/06/2024 | By Aishwarya |  272

Nucleus RadioPharma Receives Series A Extension Funding from AstraZeneca

Nucleus RadioPharma has closed its Series A extension round with new investor AstraZeneca.

Global Pharma | 06/06/2024 | By Aishwarya |  758

AstraZeneca Completes Acquisition of Fusion

AstraZeneca has completed the acquisition of Fusion Pharmaceuticals Inc., a clinical-stage biopharmaceutical company developing next-generation radioconjugates (RCs).

Global Pharma | 06/06/2024 | By Aishwarya |  502

TOPIX Pharmaceuticals Partners with University of Minnesota to Develop Groundbreaking ProteXidine Molecule

The result of nearly a decade of research, the late breaking research and ongoing scientific trials mark a breakthrough in antioxidant technology to prevent premature aging. When the skin is exposed to ultraviolet rays, Cyclobutane Pyrimidine Dimers [CPDs] are formed, also known as thymine dimers in the DNA molecule.

Global Pharma | 05/06/2024 | By Manvi |  781

Moon Surgical Gets Second FDA Clearance, Covering its Commercial Maestro Robotic Surgery System

Moon Surgical announced the United States Food and Drug Administration (FDA) clearance for the commercial version of its unique Maestro surgical system.

Global Pharma | 05/06/2024 | By Manvi |  558

Kindeva Expands UK Facilities at Charnwood Campus

Kindeva Drug Delivery has expanded their Loughborough, UK, facilities at the Charnwood Campus Science Innovation and Technology Park.

Global Pharma | 05/06/2024 | By Aishwarya |  623

UltraSight Partners with Mayo Clinic to Advance Next Generation Cardiac Care with AI

UltraSight is collaborating with Mayo Clinic on a new endeavor with the goal of enhancing cardiac care by harnessing the power of AI in point-of-care ultrasound.

Global Pharma | 04/06/2024 | By Manvi |  541